AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AIM ImmunoTech Inc.

Regulatory Filings Nov 15, 2024

Preview not available for this file type.

Download Source File

CORRESP 1 filename1.htm

SILVERMAN SHIN & SCHNEIDER PLLC Wall Street Plaza 22nd Floor 88 Pine Street NEW YORK, NY 10005 212.779.8600 Facsimile: 212.779.8858 E-mail: [email protected] __ New Jersey 19 Engle Street Tenafly, NJ 07670 (201) 567-4969

November 15, 2024

VIA EDGAR

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Re:
S-1 Registration Statement

Ladies and Gentlemen:

On behalf of AIM ImmunoTech Inc. (“AIM”) , a Delaware corporation, we hereby advise you that AIM submitted in electronic format for filing with the U. S. Securities and Exchange Commission (the “Commission”) , pursuant to the Securities Act of 1933, as amended, a registration statement on Form S-1.

Should any member of the Commission’s staff have any questions concerning the registration statement, please do not hesitate to contact me by phone (646) 822-1170, e-mail [email protected] or fax (917) 720-0863. The contact person at AIM is Peter W Rodino III, Chief Operating Officer, General Counsel & Secretary, phone (239) 444-1743, e-mail [email protected] or fax (215) 988-1739.

Very truly yours,
s/ Richard Feiner
Richard Feiner

cc: Peter Rodino

Field: Page; Sequence: 1; Options: Last

Field: /Page

Talk to a Data Expert

Have a question? We'll get back to you promptly.